Athersys Watch

from 10-Q 2 pages Assignment Agreement for Ards Clinical Doses

from 10-Q 5 pages Specific Terms in This Exhibit Have Been Redacted Because Such Terms Are Both Not Material and Are the Type That the Registrant Treats as Private or Confidential. These Redacted Terms Have Been Marked in This Exhibit With Three Asterisks [***] Exhibit 1 Fifth Amendment to Initial License Agreement

from 10-Q 3 pages C Terms in This Exhibit Have Been Redacted Because Such Terms Are Both Not Material and Are the Type That the Registrant Treats as Private or Confidential. These Redacted Terms Have Been Marked in This Exhibit With Three Asterisks [***]

from 8-K 2 pages Amendment to Series a Common Stock Purchase Warrants

from 8-K 4 pages In Consideration Thereof, You Agree to (A) Reduce the Period of the Subsequent Equity Sale Restrictions Contained in Section H)(i) of Annex a to the Warrant Exercise Inducement Offer Letter Dated October 11, 2023 Between Holder and the Company (The “October 11, 2023 Letter”) From 60 Days to 30 Days; (B) Reduce the Applicable Period in Each and All of the Provisions Relating to Restrictions on the Company (Or Any of Its Subsidiaries) Involving a “Variable Rate Transaction” (As Such Term, or a Term of Similar Meaning, Is Defined in the Applicable Document) So That Each Such Period Terminates on March 1, 2024 in All Stock Purchase Agreements, Related Letter Agreements, and All Other Related Agreements With the Holder (Including, but Not Limited to the August 17, 2023 Securities Purchase Agreement That You Entered Into With the Company, and Any Interim and Any Following Securities Purchase Agreements, as Well as the October 11, 2023 Letter); and (C) Vote as Set Forth Below in Connection With a Fundamental Transaction

from 8-K 7 pages October 11, 2023 to the Holder of August 2022, September 2022, November 2022, and August 2023 Common Stock Purchase Warrants Re: Inducement Offer to Exercise Existing Common Stock Purchase Warrants Dear Holder

from 8-K ~20 pages Athersys, Inc. 2019 Equity and Incentive Compensation Plan

from 8-K 34 pages Securities Purchase Agreement

from 10-Q 17 pages Forbearance, Restructuring and Settlement Agreement

from S-1/A 40 pages Securities Purchase Agreement

from S-1/A 36 pages Securities Purchase Agreement

from 8-K 43 pages Securities Purchase Agreement

from 10-K 1 page Summary of Athersys, Inc. 2022 Cash Bonus Incentive Plan

from 8-K 45 pages Securities Purchase Agreement Article 1 Definitions

from 8-K 26 pages Amendment No. 1 to Securities Purchase Agreement

from 8-K 36 pages Securities Purchase Agreement

from 8-K 27 pages Appendix a Athersys, Inc. 2019 Equity and Incentive Compensation Plan

from 8-K 12 pages Registration Rights Agreement

from 8-K 26 pages Common Stock Purchase Agreement

from 10-Q 17 pages Employment Agreement